You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 53 No. 3, March 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Imipramine Treatment of Alcoholics With Primary Depression

A Placebo-Controlled Clinical Trial

Patrick J. McGrath, MD; Edward V. Nunes, MD; Jonathan W. Stewart, MD; Deberah Goldman, PhD; Vito Agosti, MSW; Katja Ocepek-Welikson, MPhil; Frederic M. Quitkin, MD

Arch Gen Psychiatry. 1996;53(3):232-240.


Abstract

Background
Depressive disorders are commonly comorbid with alcoholism, particularly in treatmentseeking samples. If antidepressant treatment were safe and improved the treatment outcome in the subset of actively drinking alcoholics with depression, this would be of clinical importance.

Methods
We conducted a randomized, 12-week placebo-controlled trial of imipramine hydrochloride combined with weekly relapse prevention psychotherapy. The subjects were 69 actively drinking alcoholic outpatients with current depressive disorders. The first onset of depression was either antecedent to the abuse of alcohol or occurred during prolonged periods of sobriety. Depression and drinking outcomes at 12 weeks, as well as their relationship, were measured.

Results
Imipramine treatment was safe and associated with improvement in depression in both adequately treated and intention-to-treat samples. While there was no overall effect on drinking outcome, patients whose mood improved showed decreased alcohol consumption that was more marked in those treated with imipramine.

Conclusions
Imipramine treatment is effective for primary depression among actively drinking alcoholic outpatients, and may improve alcoholic outcome for those whose depression responds to treatment.



Author Affiliations

From the New York State Psychiatric Institute and the College of Physicians and Surgeons, Columbia University, New York, NY.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacotherapy in dual diagnosis
Crome and Myton
Adv. Psychiatr. Treat. 2004;10:413-424.
ABSTRACT | FULL TEXT  

Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
Lingford-Hughes et al.
J Psychopharmacol 2004;18:293-335.
 

Prevalence and Co-occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
Grant et al.
Arch Gen Psychiatry 2004;61:807-816.
ABSTRACT | FULL TEXT  

Treatment of Depression in Patients With Alcohol or Other Drug Dependence: A Meta-analysis
Nunes and Levin
JAMA 2004;291:1887-1896.
ABSTRACT | FULL TEXT  

Mirtazapine Improves Alcohol Detoxification
Liappas et al.
J Psychopharmacol 2004;18:88-93.
ABSTRACT  

Major Depression in 6050 Former Drinkers: Association With Past Alcohol Dependence
Hasin and Grant
Arch Gen Psychiatry 2002;59:794-800.
ABSTRACT | FULL TEXT  

Effects of Major Depression on Remission and Relapse of Substance Dependence
Hasin et al.
Arch Gen Psychiatry 2002;59:375-380.
ABSTRACT | FULL TEXT  

A Reevaluation of the Exclusion Criteria Used in Antidepressant Efficacy Trials
Posternak et al.
Am. J. Psychiatry 2002;159:191-200.
ABSTRACT | FULL TEXT  

A National Survey of Care for Persons With Co-occurring Mental and Substance Use Disorders
Watkins et al.
Psychiatr. Serv. 2001;52:1062-1068.
ABSTRACT | FULL TEXT  

Alcohol Use in Late Life: Disability and Comorbidity
Oslin
J Geriatr Psychiatry Neurol 2000;13:134-140.
ABSTRACT  

Occurrence and Management of Depression in the Context of Naltrexone Treatment of Alcoholism
Farren and O'Malley
Am. J. Psychiatry 1999;156:1258-1262.
FULL TEXT  

Drug Therapy for Alcohol Dependence
Swift
NEJM 1999;340:1482-1490.
FULL TEXT  

The Effect of Depression on Return to Drinking: A Prospective Study
Greenfield et al.
Arch Gen Psychiatry 1998;55:259-265.
ABSTRACT | FULL TEXT  

Imipramine Treatment of Opiate-Dependent Patients With Depressive Disorders: A Placebo-Controlled Trial
Nunes et al.
Arch Gen Psychiatry 1998;55:153-160.
ABSTRACT | FULL TEXT  

Drug Abuse and Addiction Treatment Research: The Next Generation
Leshner
Arch Gen Psychiatry 1997;54:691-694.
ABSTRACT  

Fluoxetine in Depressed Alcoholics: A Double-blind, Placebo-Controlled Trial
Cornelius et al.
Arch Gen Psychiatry 1997;54:700-705.
ABSTRACT  

Treating Depression in Active Alcoholics . . .
JWatch Psychiatry 1996;1996:2-2.
FULL TEXT  

Alcohol Research: At the Cutting Edge
Gordis
Arch Gen Psychiatry 1996;53:199-201.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.